Parkinson's disease

The purpose of this trial is to develop a new magnetic resonance imaging (MRI) method to accurately diagnose, predict, track progression, and monitor the response to treatment in...

Purpose This study will test a new deep brain stimulation (DBS) site that is expected to better address these features of Parkinson’s disease. Who Can Participate Parkinson’s disease...

Full Study Name: A Dose Selection Trial of Light Therapy for Impaired Sleep in Parkinson’s Disease (ENLITE PD – NN110) Description: The ENLITE PD – NN110 study is...

PPMI 2.0 is a broad program, expanding the goals of the original PPMI study (NCT01141023), that includes this PPMI 2.0 Clinical protocol, as well as the PPMI 2.0...

A Phase 3 study to evaluate efficacy, safety, and tolerability of ampreloxetine (TD-9855) in subjects with primary autonomic failures (MSA, PD, or PAF) and snOH with up to...